Ultrasensitive blood test predicts head and neck cancer relapse months earlier

Дата публикации: 10-06-2026 18:00:03

A new study by investigators from Mass General Brigham Cancer Institute has found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer cells in their bodies after surgery and may benefit the most from additional treatments. The results are published in Science Translational Medicine.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood test finds hidden pancreatic cancer after treatment	5	8	30-06-2026
2	New brush test detects oral cancer in one hour	7	8	06-07-2026
3	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
4	Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer	5	7	09-07-2026
5	Breakthrough for patients with pancreatic cancer as doctors develop new blood test that can pick up 'residue cells' of the 'silent' disease that killed Alan Rickman	8	7	30-06-2026
6	Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases	0	7	03-07-2026
7	Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis	0	7	02-07-2026
8	Reliance’s Strand Life Sciences gets patent for blood-based early cancer detection	0	5	07-07-2026
9	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.